Page last updated: 2024-10-22

beta-aminoethyl isothiourea and Angioedema

beta-aminoethyl isothiourea has been researched along with Angioedema in 1 studies

beta-Aminoethyl Isothiourea: A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.

Angioedema: Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.

Research Excerpts

ExcerptRelevanceReference
"Both normal and HANE serum lysed paroxysmal nocturnal hemoglobinuria (PNH) cells when complement was activated by acidification, CoF and inulin, indicating that the terminal steps of complement were activated in the absence of C4, presumably by the alternate or properdin pathway."1.25Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells. ( Adams, JP; Logue, GL; Rosse, WF, 1973)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Logue, GL1
Rosse, WF1
Adams, JP1

Other Studies

1 other study available for beta-aminoethyl isothiourea and Angioedema

ArticleYear
Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    The Journal of clinical investigation, 1973, Volume: 52, Issue:5

    Topics: Angioedema; beta-Aminoethyl Isothiourea; Binding Sites; Cell Membrane; Cells, Cultured; Complement F

1973